SACCARO JAMES
Chief Financial Officer
SACCARO JAMES has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: May 1, 2026.
On the most recent filing, SACCARO JAMES is listed as Chief Financial Officer at GE HealthCare Technologies Inc. Inside the rolling window, SACCARO JAMES reported 1 open-market purchase totaling $201K in GEHC and no open-market sales.
Companies traded
Other insiders at GEHC
Insider Buying
$201K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SACCARO JAMES made?
SACCARO JAMES has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does SACCARO JAMES trade?
SACCARO JAMES has filed SEC Form 4 disclosures for 1 company, including GEHC.
When was SACCARO JAMES's most recent SEC Form 4 filing?
SACCARO JAMES's most recent SEC Form 4 filing on Tracefour is dated May 1, 2026.
What is SACCARO JAMES's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, SACCARO JAMES is listed as Chief Financial Officer.
What is SACCARO JAMES's total buy and sell value in the current window?
Inside the rolling retention window, SACCARO JAMES bought $201K and sold $0 based on SEC Form 4 filings.
What was SACCARO JAMES's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 3,310 GEHC shares on 2026-05-01, worth $201K, per SEC Form 4 filings.